These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 7349693

  • 21. [Cerebroxine and the treatment of sudden deafness. Apropos of 2 representative cases].
    Van Geert G, Hennebert D.
    Brux Med; 1979; 59(11-12):515-23. PubMed ID: 534950
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Vincamine in cerebral arteriosclerosis: therapeutic effects evaluated clinically and by retinal fluoro-angiography].
    Ardito R.
    Clin Ter; 1979 Mar 15; 88(5):461-12. PubMed ID: 466968
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Studies on the vincamine-papaverine association iii. clinical use in cardiac patients.
    Pirani R, Cattani L, Tomasi AM, Masoni A.
    Agressologie; 1978 Mar 15; 19(3):221-5. PubMed ID: 736222
    [No Abstract] [Full Text] [Related]

  • 28. [Experience with the combination of vincamine and papaverine in chronic brain syndrome].
    Cacciatori D.
    Clin Ter; 1979 Jun 15; 89(5):473-82. PubMed ID: 535324
    [No Abstract] [Full Text] [Related]

  • 29. [Therapeutic use of a new vasoactive drug in cerebral vascular diseases in elderly patients].
    Petronio G, Scali G, Casa B, Nonis E.
    Clin Ter; 1980 Aug 31; 94(4):427-44. PubMed ID: 6257445
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Clinical and experimental evaluation of the use of eburnamonine in acute anc chronic cerebro-vascular insufficiency].
    Rampello L, Barbagallo G, Costanzo E, Sciacca A, Russo S.
    Clin Ter; 1981 Feb 28; 96(4):371-81. PubMed ID: 7214860
    [No Abstract] [Full Text] [Related]

  • 32. [Vincapront Retard in geriatrics. Results of a multicenter study on patients with organic psychoses].
    Hinkelmann B, Bentel U, Hangleiter P, Maisenbacher J.
    MMW Munch Med Wochenschr; 1979 Oct 26; 121(43):1427-8. PubMed ID: 119913
    [No Abstract] [Full Text] [Related]

  • 33. [Controlled testing of vincamine with special reference to the flow properties of blood].
    Klein M, Szobor A, Bräuer H.
    Med Klin; 1979 Oct 24; Suppl():29-36. PubMed ID: 542163
    [No Abstract] [Full Text] [Related]

  • 34. [Controlled clinical study on the activity of vincamine-teprosylate in the so-called aging brain syndrome].
    Passeri M, Cucinotta D, Mancini M, Bia A, Palummeri E.
    G Clin Med; 1982 Oct 24; 63(11-12):874-87. PubMed ID: 7182206
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Cerebral regulation-cerebral regulators.
    Braun P.
    Ther Hung; 1980 Oct 24; 28(3):98-104. PubMed ID: 7221974
    [No Abstract] [Full Text] [Related]

  • 38. [Agents to improve cerebrovascular circulation and cerebral metabolism--brovincamine].
    Maeda T.
    Nihon Rinsho; 1985 Feb 24; 43(2):389-91. PubMed ID: 3889412
    [No Abstract] [Full Text] [Related]

  • 39. [Evaluation of Cetal in patients with acute confusion].
    Albert E.
    Med Klin; 1979 Oct 24; Suppl():44-5. PubMed ID: 542166
    [No Abstract] [Full Text] [Related]

  • 40. [Pervincamine in the treatment of the cerebrovascular syndrome in the gerontopsychiatric patients].
    Fidetzis K, Brosteano R, Keller P.
    Med Welt; 1976 Jul 16; 27(29):1412-4. PubMed ID: 785150
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.